Kuvatris Therapeutics, Inc.
PXMDDelisted Aug 8, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001811623
Kuvatris Therapeutics, Inc. was delisted on Aug 8, 2025; its insiders filed their last Form 4 on Mar 14, 2024; no institution reported holding it in 13F filings for Q2 2025; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Kuvatris Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 13 | 9 | −4 |
| Shares | 296.2K | 110.8K | −185.4K (−62.6%) |
| Value | $85.8K | $84.2K | −$1.65K (−1.9%) |
New holders (3)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 56,441 | $43.0K | 0.00% |
| Citadel Advisors LLC | 27,973 | $21.2K | 0.00% |
| Two Sigma Securities, LLC | 11,148 | $8.44K | 0.00% |
Sold out (7)
Institutions that held Kuvatris Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Renaissance Technologies LLC | 97,100 | $28.0K |
| Vanguard Group Inc | 54,959 | $15.7K |
| Susquehanna International Group, LLP | 31,034 | $9.22K |
| Geode Capital Management, LLC | 30,781 | $9.14K |
| State Street Corp | 21,900 | $6.50K |
| HRT Financial LP | 10,773 | $3.00K |
| Bank of America Corp | 500 | $143 |